B5H7, a Morpholine Derivative of 23-Hydroxybetulinic Acid, Reverses Doxorubicin Resistance in HepG2/ADM. J. Can. Res. Updates [Internet]. 2014 Jan. 2 [cited 2025 Oct. 20];3(1): 59-66. Available from: https://neoplasiaresearch.com/index.php/jcru/article/view/550